| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.2M | -39.5% |
| R&D Expense | $69.5M | -1.2% |
| SG&A Expense | $20.7M | -9.3% |
| Operating Income | -$88.0M | +1.3% |
| Pre-tax Income | -$23.9M | +81.8% |
| Income Tax | $314K | -5.1% |
| Net Income | -$24.2M | +81.6% |
| EPS (Basic) | -$2.45 | +88.3% |
| EPS (Diluted) | -$2.45 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.3M | -50.5% |
| Short-term Investments | $59.5M | +198.6% |
| Current Assets | $82.9M | +33.3% |
| Total Assets | $88.5M | +26.3% |
| Current Liabilities | $21.2M | -2.3% |
| Total Liabilities | $35.0M | -64.7% |
| Stockholders' Equity | $53.5M | +284.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.5M | -2.2% |
| Investing Cash Flow | -$37.8M | -106.9% |
| Financing Cash Flow | $101.6M | — |
| +88.3% |